Discontinuation report APO-TERAZOSIN

Last updated on 2018-02-05 History
Report ID 4974
Drug Identification Number 02234503
Brand name APO-TERAZOSIN
Common or Proper name TERAZOSIN
Company Name APOTEX INC
Active Ingredient(s) TERAZOSIN
Strength(s) 2MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500 BTL
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for discontinuation Business reasons
Anticipated discontinuation date 2017-06-15
Actual discontinuation date 2017-06-30
Remaining supply date 2017-06-15
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments APO-TERAZOSIN 2 MG TAB 100 BTL is available
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-02-05 French Compare
v3 2018-02-05 English Compare
v2 2017-03-31 French Compare
v1 2017-03-31 English Compare